Financial results, events and calendar
/
Akero Therapeutics investor conference call
Disease areas
Science & technology
Partnering
Sustainable business
Careers
About us
Our products
Patients
Investors
News & media
Healthcare professionals
Contact us
Listen to the conference call webcast
Go to the company announcement
Open the presentation
Maziar Mike Doustdar, President and CEO
Ludovic Helfgott, EVP Product and Portfolio Strategy
Martin Holst Lange, EVP Research & Development and CSO